Article
Factors affecting response to biologic treatment in psoriasis.
Dermatologic therapy - 1 Jan 2000
Karczewski Jacek, Poniedziałek Barbara, Rzymski Piotr, Adamski Zygmunt
Abstract excerpt
Psoriasis is a chronic, immune-mediated inflammatory skin disease, affecting approximately 2-4% of the population in western countries. Patients with a more severe form of the disease are typically considered for systemic therapy, including biologics. In spite of the overall superiority of biologic agents, the treatment response may differ substantially among individual patients. As with other medical conditions,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.